Article Information
History
- December 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nicole Wolter1,2,†,
- Waasila Jassat3,
- Sibongile Walaza1,4,
- Richard Welch3,
- Harry Moultrie2,5,
- Michelle Groome3,
- Daniel Gyamfi Amoako1,6,
- Josie Everatt1,
- Jinal N. Bhiman7,8,
- Cathrine Scheepers7,8,
- Naume Tebeila1,
- Nicola Chiwandire1,
- Mignon du Plessis1,2,
- Nevashan Govender3,
- Arshad Ismail9,
- Allison Glass10,
- Koleka Mlisana11,12,
- Wendy Stevens2,11,
- Florette K. Treurnicht2,11,
- Zinhle Makatini2,11,
- Nei-yuan Hsiao11,13,
- Raveen Parboosing2,11,14,
- Jeannette Wadula2,11,15,
- Hannah Hussey16,
- Mary-Ann Davies16,
- Andrew Boulle16,
- Anne von Gottberg1,2,* and
- Cheryl Cohen1,4,*,‡
- 1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
- 2School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 3Division of Public Health Surveillance and Response, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
- 4School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 5Centre for Tuberculosis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
- 6School of Health Sciences, College of Health Sciences, University of KwaZulu-Natal, KwaZulu-Natal, South Africa
- 7Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
- 8SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 9Sequencing Core Facility, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
- 10Lancet Laboratories, Johannesburg, South Africa
- 11National Health Laboratory Service (NHLS), South Africa
- 12School of Laboratory Medicine and Medical Sciences, University of KwaZulu Natal, Durban, South Africa
- 13Division of Medical Virology, University of Cape Town, Cape Town, South Africa
- 14Department of Virology, University of KwaZulu-Natal, Durban, South Africa
- 15Department of Clinical Microbiology & Infectious Diseases, CH Baragwanath Academic Hospital, Johannesburg, South Africa
- 16Western Cape Government: Health and School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
- ↵†Corresponding author:
Dr Nicole Wolter Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, of the National Health Laboratory Service Private Bag X4, Sandringham, 2131, Gauteng, South Africa, Telephone: +27 11 555 0352, Mobile: +27 83 285 8708, E-mail: nicolew{at}nicd.ac.za - ↵‡Alternative corresponding author:
Prof Cheryl Cohen Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, of the National Health Laboratory Service Private Bag X4, Sandringham, 2131, Gauteng, South Africa, Telephone: +27 386 6593, Mobile: +27 82 572 0057, E-mail: cherylc{at}nicd.ac.za
↵* These authors contributed equally
Posted December 21, 2021.
Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa
